Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for GeneDx Holdings Corp. (WGS : NSDQ)

• Company Description    GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. Number of Employees: 1,300

• Price / Volume Information    Yesterday's Closing Price: $73.09 Daily Weekly Monthly 20 Day Moving Average: 769,288 shares Shares Outstanding: 29.82 (millions) Market Capitalization: $2,179.73 (millions) Beta: 1.95 52 Week High: $170.87 52 Week Low: $32.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.00% -15.05% 12 Week 11.35% 9.23% Year To Date -43.80% -50.19%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 333 Ludlow Street North Tower 6th Floor - Stamford,CT 06902 USA ph: 888-729-1206 fax: - investors@genedx.com http://www.genedx.com

• General Corporate Information    Officers Katherine Stueland - Chief Executive Officer and Director Jason Ryan - Chairman Kevin Feeley - Chief Financial Officer Eli D. Casdin - Director Emily Leproust - Director Peer Information GeneDx Holdings Corp. (CHCR) GeneDx Holdings Corp. (ESRX) GeneDx Holdings Corp. (MYDP) GeneDx Holdings Corp. (COR) GeneDx Holdings Corp. (GBCS) GeneDx Holdings Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 81663L200 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 10/27/26 Share - Related Items Shares Outstanding: 29.82 Most Recent Split Date: 5.00 (0.03:1) Beta: 1.95 Market Capitalization: $2,179.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.31 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.41 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/27/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 203.03 PEG Ratio: - Price Ratios Price/Book: 8.93 Price/Cash Flow: 31.89 Price / Sales: 4.80 EPS Growth vs. Year Ago Period: -98.00% vs. Previous Quarter: 103.57% Sales Growth vs. Year Ago Period: 11.44% vs. Previous Quarter: 11.92% ROE 09/30/26 - - 06/30/26 - 4.12 03/31/26 - 9.15 ROA 09/30/26 - - 06/30/26 - 2.26 03/31/26 - 5.21 Current Ratio 09/30/26 - - 06/30/26 - 3.30 03/31/26 - 3.09 Quick Ratio 09/30/26 - - 06/30/26 - 3.06 03/31/26 - 2.95 Operating Margin 09/30/26 - - 06/30/26 - 2.49 03/31/26 - 5.85 Net Margin 09/30/26 - - 06/30/26 - -23.41 03/31/26 - -17.58 Pre-Tax Margin 09/30/26 - - 06/30/26 - -23.39 03/31/26 - -17.50 Book Value 09/30/26 - - 06/30/26 - 8.19 03/31/26 - 8.57 Inventory Turnover 09/30/26 - - 06/30/26 - 10.20 03/31/26 - 11.07 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.40 03/31/26 - 0.38 Debt-to-Capital 09/30/26 - - 06/30/26 - 28.39 03/31/26 - 27.57

Powered by Zacks Investment Research ©